Genmab A/S GMAB 深 滬
等待開盤 12-13 09:30:00 美东时间
31.31
-0.990
-3.07%
華盛通- 最 高31.90
- 今 開31.81
- 成交量 193.06万股
- 最 低 31.24
- 昨 收 32.30
- 總市值 192.87亿
- 52周最高 33.65
- 市盈率 靜 17.79
- 換手率 0.31%
- 52周最低 17.235
- 委 比 -47.92%
- 總股本 6.16亿
- 歷史最高 49.07
- 量 比 1.36
- 振 幅 2.04%
- 歷史最低 16.24
- 每 手 1
- 風險率 4.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Merus Acquired by Genmab, Leadership Changes Announced
An announcement from Merus ( ($MRUS) ) is now available. On December 11, 2025, ...
12-12 21:18
Bristol Myers' Cancer Breakthrough Breyanzi Just Won Its Fifth FDA Approval
FDA approves Breyanzi, a CAR T cell therapy for relapsed or refractory marginal zone lymphoma. It has a high response rate.
12-05 21:36
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
BioNTech announced that the minimum condition for its exchange offer of CureVac shares has been met, with approximately 81.74% of CureVac's outstanding shares tendered. The subsequent offering period has begun and will expire on December 18, 2025. BioNTech will now deliver ADSs or cash to tendering CureVac shareholders, completing the transaction. Non-tendering holders will receive ADSs through the post-offer reorganization, subject to a 15% Dutc...
12-03 14:01
MHRA Approves Tisotumab Vedotin For The Treatment Of Cervical Cancer
https://www.gov.uk/government/news/mhra-approves-tisotumab-vedotin-for-the-treatment-of-cervical-cancer
12-02 23:29
美股盘前 | 存储概念股盘前普涨，SanDisk涨超4%；有机构称球存储芯片短缺加剧
存储概念股盘前普涨，SanDisk涨超4%，美光科技涨超3%，西部数据涨近2%；有机构称全球存储芯片短缺加剧，存储芯片价格预计再涨50%>>
11-28 17:33
Genmab A/S Updates Articles of Association for Financial Flexibility
The latest update is out from Genmab ( ($GMAB) ). On November 26, 2025, Genmab ...
11-26 20:28
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
BioNTech announced the approval of its exchange offer for all outstanding shares of CureVac at an extraordinary general meeting held on November 25, 2025. Over 99.16% of CureVac shareholders voted in favor of the proposals. The offer is set to expire at 9:00 am Eastern Time on December 3, 2025, with shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025. The exchange ratio is 0.05363 of a BioNTech ADS per CureVac ...
11-26 12:30
Genmab Grants Stock Units and Warrants to Employees
Genmab ( ($GMAB) ) has provided an update. On November 20, 2025, Genmab A/S ann...
11-21 04:47
Genmab A/S Discloses Managerial Share Transactions
Genmab ( ($GMAB) ) just unveiled an update. On November 19, 2025, Genmab A/S an...
11-20 03:57
AbbVie, Genmab win FDA label expansion for Epkinly in follicular lymphoma
The U.S. Food and Drug Administration (FDA) on Tuesday announced the approval of Epkinly, a bispecific antibody developed by AbbVie (ABBV) and Genmab (GMAB) for follicular lymphoma, expanding its labe...
11-19 00:34
